TY - JOUR
T1 - Understanding Experiences, Barriers, and Facilitators of Safe Airline Travel
T2 - A Global Survey of Food Allergy Patients and Caregivers
AU - Warren, Christopher
AU - Herbert, Linda
AU - Mandelbaum, Lianne
AU - Nowak-Wegrzyn, Anna
AU - Sicherer, Scott
AU - Sampson, Hugh
AU - Moassessi, Caroline
AU - Gupta, Ruchi
N1 - Publisher Copyright:
© 2024 American Academy of Allergy, Asthma & Immunology
PY - 2024/12
Y1 - 2024/12
N2 - Background: The global prevalence of food allergy (FA) has increased markedly across recent decades, with millions of patients engaging in airline travel each year. However, air travel can pose specific challenges to FA management. Objective: To collect global data about patients’ and families’ FA-related airline travel experiences, attitudes, and behaviors. Methods: An electronic survey was developed and refined by global FA stakeholders, which was administered between October 2022 and January 2023 to patients with FA and caregivers recruited via 45 FA patient advocacy organizations and research institutions. Results: Most of the 4704 survey respondents self-reported as female (88.4%), aged between 40 and 59 years (67.7%), and non-Hispanic White race (75.8%), and resided in the United States (79.6%). A history of 1 or more in-flight food-allergic reaction was reported by 8.5% of participants, with peanut (3.9%), tree nuts (2.4%), and milk (0.6%) the most reported triggers. Epinephrine was administered in 15.1% of reactions and was most often self-carried (91.7% of events). Only 57.4% of in-flight reactions were reported to either the flight crew in the air or the airline on landing. Many preventive measures were reportedly taken by respondents to avoid adverse FA outcomes during air travel, including specific requests for accommodation, which were often not provided as assured. Respondents generally reported high levels of anxiety managing FA during air travel and that FA-related policies and other related factors were primary drivers of travel-related decision making. Conclusions: Air travel presents numerous challenges to optimal FA management, many of which can be at least partially mitigated though consistent implementation of appropriate FA-related policies.
AB - Background: The global prevalence of food allergy (FA) has increased markedly across recent decades, with millions of patients engaging in airline travel each year. However, air travel can pose specific challenges to FA management. Objective: To collect global data about patients’ and families’ FA-related airline travel experiences, attitudes, and behaviors. Methods: An electronic survey was developed and refined by global FA stakeholders, which was administered between October 2022 and January 2023 to patients with FA and caregivers recruited via 45 FA patient advocacy organizations and research institutions. Results: Most of the 4704 survey respondents self-reported as female (88.4%), aged between 40 and 59 years (67.7%), and non-Hispanic White race (75.8%), and resided in the United States (79.6%). A history of 1 or more in-flight food-allergic reaction was reported by 8.5% of participants, with peanut (3.9%), tree nuts (2.4%), and milk (0.6%) the most reported triggers. Epinephrine was administered in 15.1% of reactions and was most often self-carried (91.7% of events). Only 57.4% of in-flight reactions were reported to either the flight crew in the air or the airline on landing. Many preventive measures were reportedly taken by respondents to avoid adverse FA outcomes during air travel, including specific requests for accommodation, which were often not provided as assured. Respondents generally reported high levels of anxiety managing FA during air travel and that FA-related policies and other related factors were primary drivers of travel-related decision making. Conclusions: Air travel presents numerous challenges to optimal FA management, many of which can be at least partially mitigated though consistent implementation of appropriate FA-related policies.
KW - Airline travel
KW - Anaphylaxis
KW - Anxiety
KW - Decision-making
KW - Epinephrine
KW - Food allergy
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85210750353&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2024.08.045
DO - 10.1016/j.jaip.2024.08.045
M3 - Article
AN - SCOPUS:85210750353
SN - 2213-2198
VL - 12
SP - 3372
EP - 3382
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 12
ER -